Detection of central veins using susceptibility weighted imaging (SWI) for discrimination between lesions in multiple sclerosis (MS) and cerebral small vessel disease (CSVD)
Tóm tắt
Conventional brain MRI cannot always distinguish between different white matter lesions. Susceptibility weighted imaging (SWI) can detect a sign called central vein sign which is suggested to discriminate between multiple sclerosis and other white matter lesions thus increasing the accuracy of MRI in MS diagnosis. This study aimed to evaluate the role of MR susceptibility weighted imaging in differentiating MS from CSVD lesions. The central vein sign (CVS) was found to have a premium diagnostic performance in diagnosis of MS with sensitivity 83.3%, specificity 70%, positive predictive value 80.6%, and negative predictive value 73.7%. When CVS positive lesions load was ≥ 44.24%, the specificity of CVS in diagnosing MS raised to 100%. Detection of the CVS on SWI can reliably discriminate between MS and CSVD.
Tài liệu tham khảo
Sheng H, Zhao B, Ge Y (2019) Blood perfusion and cellular microstructural changes associated with iron deposition in multiple sclerosis lesions. Frontiers in neurology, 10, 747. https://doi.org/10.3389/fneur.2019.00747.
Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurology 15(3):292–303 https://doi.org/10.1016/S1474-4422(15)00393-2
Miller DH (2004) Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 1(2):284–294 https://doi.org/10.1602/neurorx.1.2.284
Giovannoni G, Butzkueven H, Dhib-Jalbut S, Hobart J, Kobelt G, Pepper G et al (2016) Brain health: time matters in multiple sclerosis. Multiple sclerosis and related disorders 9:S5–S48 https://doi.org/10.1016/j.msard.2016.07.003
Al-Zandi SH, Fayadh NA, Al-Waely NK (2018) Central vein sign detected by SWI at 3 T MRI as a discriminator between multiple sclerosis and leukoaraiosis. The Egyptian Journal of Radiology and Nuclear Medicine 49(1):158–164 https://doi.org/10.1016/j.ejrnm.2017.09.003
Absinta M, Sati P, Gaitán MI, Maggi P, Cortese IC, Filippi M et al (2013) Seven-tesla phase imaging of acute multiple sclerosis lesions: A new window into the inflammatory process. Annals of neurology 74(5):669–678 https://doi.org/10.1002/ana.23959
Sati P, Thomasson DM, Li N, Pham DL, Biassou NM, Reich DS et al (2014) Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Multiple Sclerosis Journal 20(11):1464–1470 https://doi.org/10.1177/1352458514525868
Miller C, Goldberg MF (2012) Susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine. Emergency radiology 19(6):565–569. https://doi.org/10.1007/s10140-012-1051-2 Epub 2012 Jun 9
Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ (1995) Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. Journal of the neurological sciences 134(1):83–88 https://doi.org/10.1016/0022-510X(95)00226-7
Forbes K (2017) MRI brain white matter change: spectrum of change–how can we grade? JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH 47(3):271. https://doi.org/10.4997/JRCPE.2017.313
Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG et al (2016) The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nature Reviews Neurology 12(12):714. https://doi.org/10.1038/nrneurol.2016.166 Epub 2016 Nov 11
Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C et al (2016) Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Multiple Sclerosis Journal 22(10):1289–1296 https://doi.org/10.1177/1352458515616700
Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M et al (2018) The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nature Reviews Neurology 14(4):199 https://doi.org/10.1038/nrneurol.2018.14
Sparacia G, Agnello F, Gambino A, Sciortino M, Midiri M (2018) Multiple sclerosis: High prevalence of the ‘central vein’sign in white matter lesions on susceptibility-weighted images. The neuroradiology journal 31(4):356–361 https://doi.org/10.1177/1971400918763577
Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG et al (2011) Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology, 76(6), 534-539. https://doi.org/10.1212/WNL.0b013e31820b7630.
Lane JI, Bolster B, Campeau NG, Welker KM, Gilbertson JR (2015) Characterization of multiple sclerosis plaques using susceptibility-weighted imaging at 1.5 T: can perivenular localization improve specificity of imaging criteria? Journal of computer assisted tomography 39(3):317–320. https://doi.org/10.1097/RCT.0000000000000233
Kau T, Taschwer M, Deutschmann H, Schönfelder M, Weber JR, Hausegger KA (2013) The “central vein sign”: is there a place for susceptibility weighted imaging in possible multiple sclerosis? European radiology 23(7):1956–1962. https://doi.org/10.1007/s00330-013-2791-4 Epub 2013 Feb 22
Adams CWM, Poston RN, Buk SJ (1989) Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. Journal of the neurological sciences 92(2-3):291–306 https://doi.org/10.1016/0022-510X(89)90144-5
Lummel N, Boeckh-Behrens T, Schoepf V, Burke M, Brückmann H, Linn J (2011) Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology 53(5):311–317 https://doi.org/10.1007/s00234-010-0736-z